StockData

Insmed vs Ionis Pharmaceuticals

INSM and IONS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How INSM and IONS compare

Insmed is the larger company, worth 5.8 times as much as Ionis Pharmaceuticals ($27.0B against $4.7B).

Insmed grew revenue faster over the last twelve months (240% versus −7.4% for Ionis Pharmaceuticals).

Insmed keeps more of each dollar of sales as profit, with a net margin of −39.9% compared with −64.7% at Ionis Pharmaceuticals.

Insmed scores higher on the StockData Score (8 against 4 for Ionis Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricINSMIONS
Size and price
Market cap$27.0B$4.7B
Share price$122.88$28.01
Change, 1 year−35.7%−59.9%
Change, 5 years325%−3.6%
Beta (5Y)0.830.55
Employees1,6641,402
StockData Score
Total score8 (better)4
Valuation score01 (better)
Growth score3 (better)2
Performance score2 (better)0
Health score3 (better)1
Dividend score00
Valuation
P/S17.7×5.3× (better)
P/B37.1×10.6× (better)
FCF yield−2.3% (better)−12.0%
Fair value$61.54$28.16
Margin of safety−99.7%0.55% (better)
Growth
Revenue growth (TTM)240% (better)−7.4%
Revenue growth, 5Y average29.8% (better)5.3%
Profitability
Gross margin84.4%98.2% (better)
Operating margin−37.1% (better)−68.0%
Net margin−39.9% (better)−64.7%
FCF margin−41.3% (better)−64.2%
Return on equity−72.5% (better)−105%
Financial health
Debt / equity0.76–
Interest coverage−6.9× (better)−31.6×
Current ratio2.867.89 (better)
Altman Z-score7.51 (better)0.27
Piotroski F-score44
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions102%108%
Held by insiders0.89%0.81%
Insider net buying, 12 months−$133M−$114M (better)
Superinvestors holding11
Short interest, % of float6.5%12.8%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.